HIV-associated nephropathy incidence peaked in the mid-1990s, being reported in 3.5%â€“10% of the HIV-infected population in the USA. It was primarily in individuals of African descent, but prevalence has been declining as a result of the widespread use of combined anti-retroviral treatments.